COVID-19: Bharat Biotech recruits 23,000 volunteers for Phase III trials of Covaxin

The phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers across India.

from Latest News https://ift.tt/2Msglj0